Previous Article | Next Article 
Infection and Immunity, July 1999, p. 3601-3609, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Differential Regulation of Immune Responses by
Highly and Weakly Virulent Cryptococcus neoformans
Isolates
Rebecca
Blackstock,1,*
Kent L.
Buchanan,1,
Adekunle M.
Adesina,2 and
J.
W.
Murphy1
Department of Microbiology and
Immunology1 and Department of
Pathology,2 University of Oklahoma Health
Sciences Center, Oklahoma City, Oklahoma 73190
Received 30 November 1998/Returned for modification 30 December
1998/Accepted 20 April 1999
 |
ABSTRACT |
Early inflammatory responses, delayed-type hypersensitivity (DTH)
responses, and cytokine profiles were studied in mice infected by the
pulmonary route with either a highly virulent isolate (NU-2) or a
weakly virulent isolate (184A) of Cryptococcus neoformans. After infection, NU-2 remained in the lungs and the capsule became more
pronounced during the first 24 h, whereas 184A induced an immediate inflammatory reaction and was rapidly cleared from the lungs.
Cryptococcal antigen (GXM) appeared in sera early after infection with
NU-2 and increased over the entire observation period. There was no
detectable GXM in sera from 184A-infected mice. Both C. neoformans isolates induced anticryptococcal cell-mediated immune
responses, but the responses had different profiles. DTH in
NU-2-infected mice appeared at day 15 after infection and waned by day
21, whereas DTH in 184A-infected mice was present by day 5 and
continued to increase. T helper 1 (Th1) cytokines (interleukin 2 [IL-2] and gamma interferon) were made by spleen cells early after
infection with either isolate. NU-2-infected mice lost their ability to
produce these cytokines, but 184A-infected mice retained it. IL-4, a
Th2 cytokine, was not detected in infected mice. The regulatory
cytokine IL-10 was made by spleen cells early but not later after
infection with the highly virulent isolate and was not produced by
spleen cells from 184A-infected mice. IL-10-deficient mice survived an
NU-2 infection significantly longer than wild-type mice, suggesting
that IL-10 is important in down-regulating the protective immune
response. The induction of anergy appears to be responsible for the
inability of NU-2-infected mice to control a C. neoformans infection.
 |
INTRODUCTION |
Cryptococcus neoformans
infection is believed to be acquired by the inhalation of blastoconidia
found in debris around pigeon roosts and in the soil (26).
In the normal host, the infection typically is limited to the lung but
disseminates to other tissues in the immunosuppressed patient and in
the occasional normal host (25, 31). C. neoformans has a predilection for the brain, where it produces a
meningoencephalitis that is fatal if it is not treated with antifungal
agents (28). In the AIDS patient population, this treatment
must be continued for life (31). Although most
cryptococcosis patients have their disease diagnosed at the onset of
meningitis, the pathobiology can vary among patients. The differences
in pathogenesis could be due to differences in the ways individuals
respond to the variation in the genetic makeup of the organism.
Mouse models of cryptococcosis have been used to identify the host
responses to cryptococcosis that may provide protection from infection
(18). However, very limited information is available regarding host responses to different C. neoformans
isolates, which may vary greatly in their levels of virulence. We
reported that two such isolates display great differences in capsule
synthesis under tissue culture conditions and differ in their
pathogenic potential for mice (4). A weakly virulent
isolate, 184A, does not significantly increase its capsule size when
transferred into tissue culture conditions, i.e., RPMI 1640 in the
presence of CO2 at 37°C, while a highly virulent isolate,
NU-2, exhibits a significant increase in capsule size under the same
conditions (4). In addition, the heavily encapsulated NU-2
cells stimulate macrophages to secrete C3 when they are exposed to
cryptococcal blastoconidia in tissue cultures (4). These
results prompted us to predict that C. neoformans isolates
with the ability to produce large quantities of capsular polysaccharide
in vivo may induce very different immune responses from those induced
by isolates that produce much less capsule.
This investigation was undertaken to further define differences in host
responses to a weakly virulent isolate and a highly virulent isolate of
C. neoformans in order to identify host factors which might
contribute to the pathogenesis of the highly virulent cryptococcal
isolate. Our results showed that while the highly virulent isolate
induced a cell-mediated immune (CMI) response as detected by
delayed-type hypersensitivity (DTH) reactivity and a T helper 1 (Th1)
cytokine profile, these responses appeared early after intratracheal
infection and were rapidly down-regulated. On the other hand, infection
with the weakly virulent isolate induced a CMI response that was slower
to develop but was not down-regulated. The down-regulation of DTH and
type 1 cytokine responses in mice infected with the highly virulent
isolate could not be attributed to the production of the type 2 cytokine interleukin 4 (IL-4) during the later stages of infection but
rather to an unresponsive state of the host's effector cells. The
immunoregulatory cytokine IL-10 was significantly elevated during the
early stages of NU-2 infection, and IL-10 knockout mice were more
resistant to infection with NU-2 than their normal counterparts,
suggesting that IL-10 may contribute to the emergence of the
unresponsive state which develops later in infection.
 |
MATERIALS AND METHODS |
Animals.
CBA/J, C57BL/6J, and
C57BL/6-IL10tm1Cgn (IL-10 knockout) female mice
(7 to 8 weeks of age) were purchased from the Jackson Laboratory, Bar
Harbor, Maine, and were used in experiments when they were 8 to 16 weeks of age. The mice were housed in the University of Oklahoma Health
Sciences Center Animal Facility, which is approved by the American
Association for the Accreditation of Laboratory Animal Care.
Reagents.
RPMI 1640, penicillin-streptomycin,
L-glutamine, sodium pyruvate, essential vitamins, and
nonessential amino acids were purchased from GIBCO BRL (Grand Island,
N.Y.). HyClone (Ogden, Utah) was the supplier of fetal bovine serum
(FBS). Concanavalin A (ConA) and HEPES were purchased from Sigma
Chemical Co. (St. Louis, Mo.). Recombinant mouse IL-2 was purchased
from Collaborative Biomedical Products, Bedford, Mass. Tumor necrosis
factor alpha and gamma interferon (IFN-
) were purchased from Genzyme
(Cambridge, Mass.). PharMingen (San Diego, Calif.) was the supplier of
recombinant mouse IL-10. Recombinant mouse IL-4 was generously provided
by Sterling Winthrop (Malvern, Pa.).
Fungal strains.
The isolates of C. neoformans
used in this investigation included strain NU-2, originally obtained
from the spinal fluid of a patient with cryptococcal meningitis at the
University of Nebraska Medical Center, and strain 184A which was
obtained from L. Friedman, Tulane University Medical School. Both of
these cryptococcal isolates are encapsulated and are serotype A. The
organisms were maintained in the laboratory by growth on Sabouraud
dextrose agar.
Maintenance of endotoxin-free conditions.
To eliminate the
influence of endotoxin on experimental results, all experiments were
performed under conditions that minimize endotoxin contamination. This
included the use of endotoxin-free plasticware or glassware that was
heated for 3 h at 180°C and of reagents that contained less than
8 pg of endotoxin/ml (minimal detectable level) with the
Limulus amoebocyte lysate assay (Whittaker Bioproducts,
Inc., Walkersville, Md.).
Intratracheal infections.
Cryptococci were grown on
Sabouraud dextrose agar for 72 h, harvested from the surface of
the agar plate with sterile physiological saline solution (SPSS), and
washed three times with SPSS. Mice were anesthetized with ketamine (50 mg/kg) and xylazine (5 mg/kg), and the trachea of each mouse was
surgically exposed. A 22-gauge angiocatheter was threaded into the
trachea until the needle hub was at the level of the mouth of the
mouse. Twenty-five microliters of a solution of cryptococci (4 × 106 blastoconidia/ml) was injected into the angiocatheter
tube, followed by 50 µl of air to expel all of the inoculum from the
catheter into the lung. The incision was closed with wound clips.
Normal control mice received a sham operation with the instillation of 25 µl of SPSS into the lung instead of cryptococcal cells.
Determination of cryptococcal CFU in infected lungs.
Groups
of five mice were euthanized immediately after infection or 24 h
thereafter, respectively, to determine the number of cryptococci
deposited into the lungs and to evaluate the clearance of organisms
from the lung over the first 24 h of infection. All lobes of the
lungs were removed and placed in 5 ml of SPSS in a sterile stomacher
bag. Lungs from individual mice were homogenized with a stomacher
homogenizer (Stomacher 80 Lab Blender; Techmar). Each lung homogenate
was serially diluted in SPSS, and the dilutions were plated in
duplicate on Sabouraud dextrose agar plates. CFU were enumerated after
3 days of incubation at room temperature.
Histological examination of infected lungs.
Lungs from
experimental animals were removed at various times after infection with
C. neoformans. The lungs were fixed with buffered formalin,
sectioned, and stained with hematoxylin and eosin or with mucicarmine.
The tissues were examined for the type and intensity of cellular
infiltrate in the infected lungs, for the presence of cryptococci, and
for the amount of capsular polysaccharide associated with the
cryptococcal cells. Sections were examined in a blind fashion. The
intensity of the inflammatory responses was graded on a scale of 1 (mild) to 3 (severe), where mild represents a definite but slight
inflammatory response with cellular infiltrate detectable when compared
with lungs of sham-treated controls. The severe lesions were
characterized by an intense inflammatory infiltrate composed
predominantly of aggregates of polymorphonuclear leukocytes and few
lymphocytes. Inflammatory lesions, intermediate between these two
categories, were scored as moderate with a numeric score of 2. The
criteria for these scores were set after a careful evaluation of the
varying severity of inflammation seen in a series of experiments.
Since the inflammatory process is patchy in distribution, the extent of
lung involvement was determined by dividing each hematoxylin and
eosin-stained lung cross section into five relatively equal regions.
The presence of the inflammatory process within these regions was
determined and expressed as a percentage of the entire cross section of
the lung. Although the lungs were not inflated, by comparing
experimental lungs to lungs of sham-treated mice we were able to rule
out lung collapse as a factor in our assessment.
Measurement of serum GXM levels.
Titers of the cryptococcal
antigen glucuronoxylomannan (GXM) in the sera of experimental animals
were determined by using a commercially available latex agglutination
assay (Immuno-Mycologics, Inc., Norman, Okla.). Serial twofold
dilutions of serum were tested for the ability to agglutinate latex
particles coated with anti-GXM according to the manufacturer's protocol.
Preparation of cryptococcal antigen.
Cryptococcal culture
filtrate antigen (CneF) was prepared from C. neoformans 184A
as described previously (5). The preparation used in this
investigation had a protein content of 243 µg/ml as determined by the
bicinchoninic acid assay (Pierce Chemical Co., Rockford, Ill.) and a
carbohydrate concentration of 3.2 mg/ml as determined by the
phenol-sulfuric acid assay (11). When tested in the
Limulus assay, this lot of CneF gave a reaction equivalent to less than 0.1 ng of endotoxin/ml. Because the extract contains a
high concentration of GXM, which gives a positive reaction in the
Limulus assay due to its content of glucuronic acid
(32), this Limulus reactivity is considered to be
due to the glucuronic acid rather than to endotoxin contamination.
Elicitation of the anticryptococcal DTH response.
Hind
footpads of mice were measured with a gauge micrometer (Mitutoyo,
Aurora, Ill.), 30 µl of SPSS was injected in the left footpad, and 30 µl of CneF was injected in the right footpad. The footpads were
measured again 24 h later.
The increase in footpad thickness was calculated as the difference in
swelling between the 0- and 24-h measurements. Specific
DTH reactivity
was calculated as the difference between the swelling
of the
SPSS-injected footpads and the swelling of the CneF-injected
footpads.
In vitro stimulation of cytokine synthesis by spleen cells.
Spleen cells were harvested from groups of mice at various times after
intratracheal infection with C. neoformans NU-2 or 184A.
Single cell suspensions were prepared by pressing the spleens through a
sterile 60-mesh wire screen into sterile Hanks' balanced salt
solution-3% FBS. Erythrocytes were lysed with 0.83% ammonium chloride, and the mononuclear cells were washed three times in Hanks'
balanced salt solution-FBS. The cells were then suspended in
Bretcher's medium (RPMI 1640 containing 100 U of penicillin per ml,
100 µg of streptomycin per ml, 25 mM HEPES, 5 × 10
3 M 2-mercaptoethanol, 2 mM L-glutamine, 1 mM sodium pyruvate, 1% essential vitamins, 1% nonessential amino
acids, and 10% FBS). The spleen cells at a concentration of 5 × 106/ml were stimulated with cryptococcal CneF at a final
dilution of 1:8, with concanavalin A (25 µg/ml) as a positive
control, or they were cultured without stimulation to determine the
constitutive or background level of cytokine secretion. Cultures were
incubated at 37°C in an atmosphere of 5% CO2, and
supernatant fluids were collected 24 and 48 h after the initiation
of cultures for the assessment of cytokines.
Quantitation of cytokine levels in culture supernatants.
Enzyme-linked immunosorbent assays for the detection of IL-2, IFN-
,
IL-4, and IL-10 in tissue culture supernatants were constructed by
using commercially available paired monoclonal antibodies for each
cytokine (PharMingen) according to our previously described method
(30). The minimal levels of detection for the IL-2, IL-4, IL-10, and IFN-
assays were 4 pg/ml, 6.25 pg/ml, 200 pg/ml, and 128 pg/ml, respectively.
Determination of survival after infection with C. neoformans.
The virulence of cryptococcal isolate NU-2 was
determined in C57BL/6J mice and in the IL-10 knockout strain
C57BL/6-IL10tm1Cgn. Nineteen mice of each strain
were infected by the intratracheal route with 105 C. neoformans NU-2 organisms. The animals were observed daily for
deaths, to determine the mean survival time in the normal and IL-10
knockout mouse strains.
Statistical analysis.
The significant differences between
experimental groups were evaluated by Student's t test.
Survival data were analyzed by Kaplan-Meier survival plots followed by
log rank tests. Data with a P value of 0.05 or less were
considered to be significant.
 |
RESULTS |
Clearance of cryptococcal isolates NU-2 and 184A from infected
lungs.
The ability of the host to clear NU-2 or 184A was assayed
by the determination of CFU in infected lungs immediately after infection and 24 h after infection. Cryptococcal isolates were grown on Sabouraud dextrose agar, a medium previously shown to allow
limited capsule production in both isolates (4). Cryptococci were harvested from these cultures and used to infect the lungs of
CBA/J mice. The CFU analysis revealed that isolate 184A was virtually
eliminated from the lungs during the first 24 h of infection (Fig.
1). On the other hand, NU-2-infected mice
had similar numbers of CFU in their lungs immediately after inoculation
(day 0) and at 24 h.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
CFU cultured from the lungs of mice immediately or
24 h after intratracheal infection with C. neoformans
NU-2 or 184A. *, statistically significant (P < 0.001) compared to NU-2-infected lungs 24 h after infection.
The data presented represent the mean CFU ± standard errors of
the means (error bars) for five animals/experimental group.
|
|
Histological examination of lungs of mice infected with
cryptococcal isolates NU-2 and 184A.
Lung tissue taken from mice
infected 24 h earlier with NU-2 displayed cryptococcal cells
associated with a mixed inflammatory response consisting of neutrophils
and mononuclear cells (Fig. 2A). In the
lungs from 184A-infected mice no cryptococci could be seen but mixed
inflammatory infiltrates were evident (Fig. 2C). A direct comparison of
an area of inflammation adjacent to tissue without inflammatory cells
is seen in Fig. 3A. The identification of
polymorphonuclear leukocytes at 24 h in NU-2-infected lungs can be
seen more clearly at a higher magnification (Fig. 3B). The lungs of
experimental mice were examined at several different levels, and in
both the NU-2- and 184A-infected groups, patchy inflammatory reactions
were distributed throughout the lung in focally cellular areas.
Mucicarmine-stained sections of NU-2-infected lungs revealed many
cryptococci with large capsules (Fig. 2B), whereas similarly stained
sections of 184A-infected lungs showed no evidence of the organism
(Fig. 2D). The findings in the histological sections corroborated the
observations of disparate cryptococcal CFU numbers isolated from lungs
between 0 and 24 h after infection with NU-2 or 184A.

View larger version (131K):
[in this window]
[in a new window]
|
FIG. 2.
Lung sections taken from mice 24 h after infection
with C. neoformans NU-2 (A and B) or 184A (C and D).
Sections were stained with hematoxylin and eosin (A and C) or
mucicarmine (B and D). There were three mice in each experimental
group. Photomicrographs are from one representative animal from each
group. Encapsulated cryptococcal cells are indicated by the arrows.
Magnification, ×200 (A and C) or ×400 (B and D).
|
|

View larger version (103K):
[in this window]
[in a new window]
|
FIG. 3.
Lung section taken 24 h after infection with
C. neoformans NU-2. Shown in both panels is normal lung
tissue (lower left) adjacent to patchy inflammed tissue (central and
lower right). Magnification, ×200 (A) or ×400 (B), with
polymorphonuclear leukocytes indicated by the arrows.
|
|
The hematoxylin and eosin-stained sections of lungs from infected mice
taken over the first 24 h of infection were graded
in a blind
fashion for the intensity of the inflammatory response.
In addition,
each lung was assessed for the percentage of the
lung tissue in which
inflammation could be observed. The intensity
of the inflammatory
response was higher during the first 3 h of
infection when the
mice were infected with the 184A isolate (Table
1). In addition, the percentage of lung
tissue in which inflammation
was present was statistically higher in
the 184A-infected lungs
when assessed after 1 h of infection
(
P = 0.0079) than in NU-2-infected
lungs at 1 h
(Table
1). The percent involvement of the inflammatory
response in the
184A-infected lungs was significantly lower by
3 h of infection
(
P = 0.0144) than in 184A-infected lungs at 1
h,
while the inflammation of NU-2-infected lungs appeared to increase
in
intensity with time. When the percentage of lung involvement
was
compared at 1, 3, 12, and 24 h in the NU-2-infected mice,
the
differences were not significant from one time period to the
next. The
inability to obtain statistical differences could be
due to the small
numbers of mice in each group. However, the percent
involvement of
NU-2-infected lungs pooled from the early (1 and
3 h) time points
(11.8% ± 2.02%) and the percent involvement of
NU-2-infected lungs
from the later (12 and 24 h) time points (36.2%
± 9.3%) were
significantly different (
P = 0.0079).
Serum GXM levels in mice infected with cryptococcal isolates NU-2
and 184A.
GXM levels in the sera of mice infected with NU-2 or
184A were evaluated weekly over the first 5 weeks of infection.
Elevated GXM levels were found in NU-2-infected mice as early as 7 days after infection, and these levels continued to rise over the 5-week observation period (Fig. 4). GXM could
not be detected in 184A-infected mice at any time during the 5-week
observation period.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Serum GXM concentrations in mice infected with NU-2 and
184A. Data presented are means ± standard errors of the means
(SEM) (error bars) for three to five individual mice tested at each
time period.
|
|
DTH responses in mice infected with cryptococcal isolates NU-2 or
184A.
Mice were assayed for their abilities to respond to
cryptococcal culture filtrate (CneF) antigen with a DTH response at 15, 21, and 28 or 29 days after infection. The results are shown in Fig.
5. NU-2-infected mice developed a strong
DTH reaction early in the infection (day 15), whereas 184A-infected
mice showed peak DTH reactivity later (day 28 to 29). By the 21st day
of infection with NU-2, the DTH response was waning. On the other hand,
DTH responsiveness in the 184A-infected mice increased throughout the
entire observation period. In addition, the DTH response of 184A-infected animals at the day 28 to 29 was significantly higher than
the DTH response of NU-2-infected mice tested at this same time period
(P = 0.0003).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 5.
DTH footpad reaction to cryptococcal CneF antigen in
CBA/J mice infected with C. neoformans NU-2 or 184A.
Statistically significant (P = 0.0003) data compared to
the DTH response of NU-2-infected mice at 28 to 29 days of infection
(*) and statistically significant (P = 0.02) data
compared to the response of NU-2-infected mice at day 15 of infection
(**) are indicated. The data shown are combined from two separate
experiments and represent the mean increases in paw thickness ± standard errors of the means (error bars) for three to nine
animals/time period.
|
|
Cytokine responses in mice infected with cryptococcal isolates NU-2
and 184A.
Cytokines associated with Th1 (IL-2 and IFN-
) cells,
Th2 (IL-4) cells, and the regulatory cytokine IL-10 were examined in NU-2- and 184A-infected mice over the first 27 to 30 days of infection. CBA/J mice were infected intratracheally, and their spleen cells were
removed at various times after infection. Spleen cells were cultured in
tissue culture medium alone or in a medium containing CneF for 24 h (IL-2 analysis) or 48 h (all other cytokines). Supernatant fluids were collected, and the concentration of each cytokine was
assessed by an enzyme-linked immunosorbent assay specific for each
cytokine. Spleen cells from age-matched, uninfected, sham-treated CBA/J
mice were cultured under identical conditions to obtain information
regarding the response of normal spleen cells to the cryptococcal
antigen CneF. CneF did not induce the production of IL-2, IL-4, or
IL-10 by normal spleen cells. However, CneF did stimulate normal spleen
cells to produce low levels of IFN-
. ConA controls were also
included (data not shown) which provided evidence that the cells
remained viable under our tissue culture conditions and that there were
cells present in the spleens that were capable of secreting each of the
cytokines studied.
Constitutively produced levels of IL-2 by spleen cells from mice
infected with either isolate were not significantly higher
than levels
made by spleen cells of sham-treated controls. CneF-stimulated
spleen
cells removed early (day 9 to 15) after infection with
NU-2 produced
larger amounts of IL-2 than did similarly treated
spleen cell cultures
from 184A-infected mice (Fig.
6). While
the
difference between the groups was not statistically significant
due
to large variation between individual mice, this observation
was
consistently observed in repeat experiments. Between days
18 and 21, spleen cells from NU-2- or 184A-infected mice did not
produce IL-2 when
stimulated with CneF. A second cycle of IL-2
production was found with
CneF-stimulated spleen cells from 184A-infected
mice starting at 24 days of infection. The levels of IL-2 produced
by CneF-stimulated
spleen cells from 184A-infected mice were significantly
(
P = 0.04) higher than the levels detected in supernatant fluids
from
CneF-stimulated spleen cells from NU-2-infected mice at the
24- and
27-day time periods.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 6.
IL-2 secreted by spleen cells taken from CBA/J mice at
various times after infection with C. neoformans NU-2 or
184A. Spleen cells were cultured with or without the addition of
cryptococcal antigen CneF, and supernatants were harvested 24 h
after the initiation of culture. There was no difference in IL-2 levels
between the medium alone and CneF-stimulated cultures when spleen cells
were harvested from sham-treated mice; therefore, the data shown as
dashed horizontal lines represent the variation (± standard errors of
the means [SEM]) of the cytokine response of the sham-treated
controls to medium alone and to CneF. *, statistically significant
(P = 0.04) compared to IL-2 secretion from spleen cells
of NU-2-infected mice at day 24 or 27 of infection. Vertical error bars
represent the variation (±SEM). There were three to four animals in
each experimental group, and the experiment was repeated once.
|
|
CneF-induced IFN-

responses of spleen cells from animals infected
with either cryptococcal isolate were at a relatively high
level by the
15th or 20th day of infection (Fig.
7).
At day 15,
CneF-stimulated spleen cells from NU-2-infected mice
repeatedly
produced more IFN-

than similarly stimulated spleen cells
from
the 184A-infected animals, but the difference was not
statistically
significant. The ability of spleen cells to produce
IFN-

after
stimulation with CneF continued to increase in both
groups of
infected mice until day 20. IFN-

production decreased in
both
groups at day 24 of infection. Despite this diminution, the levels
of IFN-

in supernatant fluids from CneF-stimulated spleen cells
from
184A-infected animals at day 24 and thereafter were still
quite
substantial in magnitude and were significantly greater
than those
detected in supernatant fluids from CneF-stimulated
spleen cells from
mice infected with NU-2 (Fig.
7 [
P = 0.049 at
day 24;
P = 0.0002 at days 27 and 30).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 7.
IFN- secreted by spleen cells taken from CBA/J mice
at various times after infection with C. neoformans NU-2 or
184A. Spleen cells were cultured with or without the addition of
cryptococcal antigen CneF, and supernatants were harvested 48 h
after the initiation of culture. There was a difference in the IFN-
level between the medium alone and CneF-stimulated cultures when spleen
cells were harvested from sham-treated mice; therefore, the data shown
for the medium response (± standard errors of the means [SEM])
(error bars) are presented as the horizontal dotted lines, and the
response to CneF (±SEM) is represented as horizontal dashed lines.
Statistically significant (P = 0.049) data compared to
IFN- secretion by spleen cells from NU-2-infected mice at day 24 after infection (*) and statistically significant (P < 0.0002) data compared to the secretion of IFN- by spleen cells
of NU-2-infected mice at day 27 or 30 after infection (**) are
indicated. Vertical error bars represent the variation (±SEM). There
were five to six animals/experimental group, and the experiment was
repeated once.
|
|
IL-4 responses of spleen cells taken from mice which were infected with
C. neoformans 184A or NU-2 were not statistically
different
from responses of spleen cells from sham-treated mice
either after no
stimulation or in response to cryptococcal CneF
antigen (Fig.
8). For this reason we cannot establish a
role for
IL-4 as a factor in the immunosuppressive consequences of
infection
with cryptococcal isolate NU-2.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 8.
IL-4 secreted by spleen cells taken from CBA/J mice at
various times after infection with C. neoformans NU-2 or
184A. Spleens were cultured with or without the addition of
cryptococcal antigen CneF, and supernatants were harvested 48 h
after the initiation of culture. There was no difference in IL-4 levels
between the medium alone and CneF-stimulated cultures when spleen cells
were harvested from sham-treated mice; therefore, the data shown as
dashed horizontal lines represent the variation (± standard errors of
the means [SEM]) of the cytokine response of the sham-treated
controls to medium alone and to CneF. Vertical error bars represent the
variation (±SEM). There were five to six animals/experimental group,
and the experiment was repeated once.
|
|
IL-10 production at levels above those from sham-treated mouse spleen
cells was observed only in supernatant fluids from CneF-stimulated
spleen cells from NU-2-infected mice (Fig.
9). The CneF-stimulated
spleen cells from
NU-2-infected animals exhibited significantly
elevated (
P = 0.04) levels of IL-10 early (day 15) in infection
compared to
those from 184A-infected mice. After the 15th day
of NU-2 infection,
IL-10 was not produced after the stimulation
of spleen cells with CneF
and was not present in significantly
higher quantities than could be
detected in cultures of spleen
cells of sham-treated mice. The level of
constitutive secretion
of IL-10 by spleen cells of 184A-infected mice
was no higher than
constitutive levels of IL-10 found in culture
supernatants of
spleen cells from sham-treated mice. In addition, CneF
did not
stimulate IL-10 secretion from spleen cells from 184A-infected
mice (Fig.
9).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 9.
IL-10 secreted by spleen cells taken from CBA/J mice at
various times after infection with C. neoformans NU-2 or
184A. Spleen cells were cultured with or without the addition of
cryptococcal antigen CneF, and supernatants were harvested 48 h
after the initiation of culture. There was no difference in IL-10
levels between the medium alone and CneF-stimulated cultures when
spleen cells were harvested from sham-treated mice; therefore, the data
shown as dashed horizontal lines represent the variation (± standard
errors of the means [SEM]) of the cytokine response of the
sham-treated controls to medium alone and to CneF. Statistically
significant (P = 0.04) data compared to IL-10 secretion
from spleen cells of 184A-infected mice at day 15 after infection (*)
are indicated. Vertical error bars represent the variation (±SEM).
There were three to four animals in each experimental group, and the
experiment was repeated once.
|
|
Survival of normal and IL-10 knockout mice infected with C. neoformans NU-2.
Because significant elevations in IL-10
secretion levels by CneF-stimulated spleen cells from NU-2-infected
mice were observed, we assessed how IL-10 may relate to virulence.
Survival studies were done in NU-2-infected normal mice (C57BL/6J) and
C57BL/6J mice containing a targeted disruption of the IL-10 gene (IL-10 knockout mice). The survival curves are shown in Fig.
10. The mean survival time of C57BL/6
mice was 36.4 ± 4.24 days, whereas the IL-10 knockout mice
survived significantly (P = 0.0002) longer with a mean
survival time of greater than 65.3 ± 7.1 days. All of the C57BL/6
mice had expired by the 85th day of infection, and the experiment was
terminated at the 100th day with 8 of the 19 NU-2-infected IL-10
knockout mice still surviving.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 10.
Survival of C57BL/6J or IL-10 knockout mice infected by
the intratracheal route with 105 C. neoformans
NU-2 organisms. The survival rate of IL-10 knockout mice was
significantly higher (P = 0.0002) than that of C57BL/6J
mice. Data represent the survival rates for 19 animals/mouse strain.
|
|
 |
DISCUSSION |
Previous reports from our laboratories showed that cryptococcal
isolates which vary in their virulence for mice can be differentiated by their abilities to up-regulate the amount of capsule produced when
grown under tissue culture conditions (4). In addition, the
increased expression of capsule on the highly virulent isolate is
responsible, in part, for the induction of increased secretion of the
third component of complement by normal peritoneal macrophages (4). Differences in survival rates for NU-2-infected mice
and 184A-infected mice and the induction of secretion of this
inflammatory mediator by NU-2-stimulated macrophages suggest that the
amount of capsule expressed in vivo by the cryptococcal isolates might contribute to differences in the early inflammatory responses elicited
and subsequently to the type of immune response that develops during infection.
Analysis of the clearance of cryptococcal cells from the lungs of mice
infected with highly and weakly virulent isolates revealed that the
weakly virulent isolate was cleared rapidly, whereas the highly
virulent isolate remained in the lungs in stable numbers over the first
24 h after infection. At the time of infection, the capsules of
NU-2 and 184A were similar in size (data not shown). This observation
is in agreement with our previous findings that capsule size is similar
for these two isolates when they are grown on Sabouraud medium
(4). Histological analysis indicated that NU-2 up-regulated
capsule synthesis within 24 h of infection. This suggestion was
corroborated by our finding that soluble capsular polysaccharide was
found in the sera from NU-2-infected mice as early as 7 days after
infection. The poor clearance of NU-2 from the lungs then may be due to
the fact that NU-2 develops a large capsule that is protective against
phagocytosis (6, 24).
The weakly virulent isolate, 184A, remained in the lungs less than
24 h after infection, which was such a short period, and the
numbers of organisms were so low, that we were unable to assess the
capsule size in lung tissue. However, it might be assumed from data
derived from in vitro tissue culture studies and the lack of serum
cryptococcal antigen titers in 184A-infected mice that 184A did not
up-regulate its capsule synthesis to a significant degree in the lungs.
Our inability to find 184A cells in the lungs beyond 24 h is in
accord with an earlier report (27), in which 184A could not
be cultured from the lungs of mice infected intranasally. In that
earlier report, 95% of the mice developed DTH responses and viable
cryptococci were cultured from extrapulmonary tissues of at least 50%
of the mice at some time after infection. In the present study, 100%
of the 184A-infected mice had positive anticryptococcal DTH reactions
by day 21 or 28 of infection. The combined data demonstrate that
184A-infected animals were indeed infected and that 184A is not
completely cleared from the body after infection via the lungs even
though the lungs appear sterile.
Histological analysis of infected lungs also provided important
information regarding the early inflammatory response to these two
cryptococcal isolates. While an acute inflammatory response was
elicited after infection with both cryptococcal strains, the weakly
virulent isolate (184A) elicited a response that tended to be more
intense during the first 3 h of infection. In addition, more of
the lung was involved early after 184A was introduced into the lungs
than in lungs from NU-2-infected mice. At 12 and 24 h after
infection, the inflammatory response was diminished in mice infected
with 184A. On the other hand, the intensity of the inflammatory
response and the percent lung involvement increased with time over the
first 12 h when mice were infected with the highly virulent
isolate NU-2.
Associations of protection against C. neoformans with an
anticryptococcal CMI response and a Th1 cell response, i.e., the production of IL-2 and IFN-
, have been made by several groups of
investigators (1, 9, 15, 19, 21-23, 27, 37). To determine
how the level of CMI responsiveness related to the progression of
cryptococcosis, we followed the anticryptococcal CMI responsiveness as
determined by the level of anticryptococcal DTH reactivity and the
cytokine profiles in response to cryptococcal antigen. Results in both
DTH and Th1 cytokine production assays indicated that mice infected
with the highly virulent or weakly virulent isolate developed
anticryptococcal CMI responsiveness. After the initial anticryptococcal
immune responsiveness (DTH and Th1 cytokine production) was observed,
mice infected with the highly virulent isolate were unable to sustain
during the later stages of disease either the anticryptococcal DTH
response or the ability to produce Th1 cytokines. In contrast, mice
infected with the weakly virulent isolate were delayed in the
development of an anticryptococcal DTH response but retained their
ability to display the anticryptococcal DTH responsiveness, and
their spleen cells retained the ability to react to cryptococcal
antigen with the production of IFN-
. IFN-
has been shown to be
protective against C. neoformans (14, 20, 29), so
it is reasonable to predict that the inability of the NU-2-infected
mice to produce IFN-
would leave the animals vulnerable to
progressive infection with C. neoformans.
A cryptococcus-specific Th2 response did not appear to be induced,
because the level of the Th2 cell-associated lymphokine IL-4 was not
significantly elevated above background levels at any time after
infection with either the highly virulent or the weakly virulent
isolate. From these findings one might conclude that Th2 cells, if
induced, are induced at low or undetectable levels. Consequently, one
would not expect Th2 cells and their cytokines to be responsible for
the observed inability of spleen cells from NU-2-infected mice to make
Th1 cytokines when stimulated with cryptococcal antigen. Our conclusion
that Th2 cells or their cytokines are not responsible for the
diminution of Th1 cell-associated cytokines and the lack of protection
in the NU-2-infected mice is in agreement with that of Hoag and
coworkers (16), who reported that the susceptibility of
C57BL/6 mice to C. neoformans infection cannot be clearly
attributed to the induction of Th2 cells.
Because of the inability of spleen cells from NU-2-infected mice to
produce any cytokines in response to cryptococcal antigen during the
later part of the disease, we postulate that the NU-2-infected mice
developed anergy. Functionally impaired CD4+ T cells have
been shown to be induced and to persist for prolonged periods in vivo
in mice made tolerant to ovalbumin by injecting the antigen
intravenously (33). In the ovalbumin model, there is an
early transient responsiveness of T cells followed by the lack of an
ability to make cytokines, and this unresponsiveness is independent of
Th2 cells (33). The immune response in the NU-2-infected
mice follows a pattern similar to that seen in the ovalbumin model, in
which tolerance is induced.
IL-10 is a cytokine that is made primarily by macrophages and
B-lymphocytes (17) and is known to down-regulate the Th1
response (13). IL-10 was transiently produced by spleen
cells from NU-2-infected mice but not 184A-infected mice when
stimulated with cryptococcal antigen, so it is possible that IL-10
either alone or in conjunction with other cytokines is responsible for
down-regulating the Th1 response in NU-2-infected mice. IL-10 is known
to contribute to immunosuppression in other infectious diseases
(3), and the expression of IL-10 in human immunodeficiency
virus-positive individuals correlates with the early loss of Th
function (7), so there is some precedent for this
speculation. It is possible that IL-10 does contribute to the
unresponsiveness that subsequently is detected in NU-2-infected mice
due to its ability to deactivate macrophages and other
antigen-presenting cells (APC) (10). IL-10 regulates the
production or action of IL-12 (8), IL-18 (35),
and tumor necrosis factor alpha (34) by macrophages, thereby
inhibiting the production of cytokines that are known to be important
for the induction of protective immunity in cryptococcosis
(19). If APC function is eliminated by this mechanism, then
subsequent T-cell activation by cryptococcal antigen may be negated,
thereby preventing the further production of IL-2 and IFN-
by
activated T cells. The effects on APC function may favor the induction
of unresponsiveness in both the Th1 cells and Th2 cells that are specific for cryptococcal antigen. IL-10 has been reported to be
involved in the induction of anergy of T cells during specific immunotherapy for allergic disease (2) and to enhance the
induction of tolerance to the contact allergen
2,4,6-trinitrochlorobenzene (12).
We have not yet studied the cellular subpopulation that may be
responsible for secreting IL-10 during cryptococcal infection. Because
it is known that the cryptococcal capsular polysaccharide can cause
human monocytes to secrete IL-10 (36), it is possible that
macrophages and not lymphocytes are responsible for the production of
IL-10 in NU-2-infected mice. Enhanced IL-10 secretion in response to
NU-2 may then reflect the increase in capsule production that is
detected on the NU-2 cell. While the GXM antigen that is in our CneF
preparation would also be expected to stimulate the secretion of IL-10
from macrophages of normal mice and 184A-infected mice, we cannot
exclude the possibility that the macrophages in the spleens of
NU-2-infected mice secrete more IL-10 in response to GXM, due to a
difference in their states of activation.
By introducing an infection with NU-2 via the pulmonary route in mice
that were unable to produce IL-10 we were able to determine whether
IL-10 displayed a negative regulatory activity on the protective
anticryptococcal immune response. IL-10-deficient mice survived
significantly longer than wild-type mice, demonstrating that mice
without IL-10 were better able to control the C. neoformans infection with the highly virulent isolate than mice with the potential
to produce IL-10 in response to C. neoformans infection. This observation, combined with the observation that IL-10 was made by
spleen cells in response to cryptococcal antigen at a time in infection
prior to the loss of the animals' ability to mount an anticryptococcal
DTH reaction and make IFN-
, supports the concept that IL-10 plays
some role in the anergy observed and the reduced ability of the mice to
control the C. neoformans infection.
 |
ACKNOWLEDGMENTS |
We thank Fredda Schafer and Anny Alsup for their excellent
technical assistance.
This work was supported by Public Health Service grants AI-15716
(J.W.M.), AI18895 (J.W.M.), HL-59852 (J.W.M.), and AI43325 (R.B.) and
by the Presbyterian Health Foundation (R.B.). K.L.B. is a Burroughs
Wellcome Fund New Investigator in Molecular Pathogenic Mycology.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, University of Oklahoma Health Sciences
Center, P.O. Box 26901, Oklahoma City, OK 73190. Phone: (405) 271-4854. Fax: (405) 271-3117. E-mail: becky-blackstock{at}ouhsc.edu.
Present address: Department of Microbiology and Immunology, Tulane
University Medical Center, New Orleans, LA 70112.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Aguirre, K.,
D. A. Havell,
G. W. Gibson, and L. L. Johnson.
1995.
Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice.
Infect. Immun.
63:1725-1731[Abstract].
|
| 2.
|
Akdis, C. A. B. T.,
M. Akdis,
B. Wuthrich, and K. Blaser.
1998.
Role of interleukin 10 in specific immunotherapy.
J. Clin. Investig.
102:98-106[Medline].
|
| 3.
|
Bermudez, L. E., and J. Champsi.
1993.
Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice.
Infect. Immun.
61:3093-3097[Abstract/Free Full Text].
|
| 4.
|
Blackstock, R., and J. W. Murphy.
1997.
Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.
Infect. Immun.
65:4114-4121[Abstract].
|
| 5.
|
Buchanan, K. L., and J. W. Murphy.
1993.
Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.
Infect. Immun.
61:2854-2865[Abstract/Free Full Text].
|
| 6.
|
Bulmer, G. S., and M. D. Sans.
1968.
Cryptococcus neoformans. III. Inhibition of phagocytosis.
J. Bacteriol.
95:5-8[Abstract/Free Full Text].
|
| 7.
|
Clerici, M.,
T. A. Wynn,
J. A. Berzofsky,
S. P. Blatt,
C. W. Hendrix,
A. Sher,
R. L. Coffman, and G. M. Shearer.
1994.
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with human immunodeficiency virus.
J. Clin. Investig.
93:768-774.
|
| 8.
|
Dandrea, A.,
M. Asteamezaga,
N. M. Valiante,
X. J. Ma,
M. Kubin, and G. Trinchieri.
1993.
Interleukin-10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
J. Exp. Med.
178:1041-1048[Abstract/Free Full Text].
|
| 9.
|
Decken, K.,
G. Köhler,
K. Palmer-Lehmann,
A. Wunderlin,
F. Mattner,
J. Magram,
M. K. Gately, and G. Alber.
1998.
Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans.
Infect. Immun.
66:4994-5000[Abstract/Free Full Text].
|
| 10.
|
Ding, L.,
P. S. Linsley,
L. Y. Huang,
R. N. Germain, and E. M. Shevach.
1993.
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.
J. Immunol.
151:1224-1234[Abstract].
|
| 11.
|
Dubois, M.,
K. A. Gilles,
J. K. Hamilton,
P. A. Rebers, and F. Smith.
1956.
Colorimetric method for determination of sugars and related substances.
Anal. Chem.
28:350-356.
|
| 12.
|
Enk, A. H.,
J. Saloga,
D. Becker,
M. Mohamadzadeh, and J. Knop.
1994.
Induction of hapten-specific tolerance by interleukin-10 in vivo.
J. Exp. Med.
179:1397-1402[Abstract/Free Full Text].
|
| 13.
|
Fiorentino, D. F.,
M. W. Bond, and T. R. Mosemann.
1989.
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.
J. Exp. Med.
170:2081-2095[Abstract/Free Full Text].
|
| 14.
|
Flesch, I. E. A.,
G. Schwamberger, and S. H. E. Kaufmann.
1989.
Fungicidal activity of IFN-gamma-activated macrophages extracellular killing of Cryptococcus neoformans.
J. Immunol.
142:3219-3224[Abstract].
|
| 15.
|
Hoag, K. A.,
M. F. Lipscomb,
A. A. Izzo, and N. E. Street.
1997.
IL-12 and IFN- are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice.
Am. J. Respir. Cell Mol. Biol.
17:733-739[Abstract/Free Full Text].
|
| 16.
|
Hoag, K. A.,
N. E. Street,
G. B. Huffnagle, and M. F. Lipscomb.
1995.
Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice.
Am. J. Respir. Cell Mol. Biol.
13:487-495[Abstract].
|
| 17.
|
Howard, M., and A. Ogarra.
1992.
Biological properties of interleukin-10.
Immunol. Today
13:198-200[Medline].
|
| 18.
|
Huffnagle, G. B.,
M. F. Lipscomb,
J. A. Lovchik,
K. A. Hoag, and N. E. Street.
1994.
The role of CD4(+) and CD8(+) T cells in the protective inflammatory response to a pulmonary cryptococcal infection.
J. Leukoc. Biol.
55:35-42[Abstract].
|
| 19.
|
Huffnagle, G. B.,
G. B. Toews,
M. D. Burdick,
M. B. Boyd,
K. S. McAllister,
R. A. McDonald,
S. A. Kunkle, and R. M. Strieter.
1996.
Afferent phase production of TNF- is required for the development of protective T cell immunity to Cryptococcus neoformans.
J. Immunol.
157:4529-4536[Abstract].
|
| 20.
|
Kawakami, K.,
S. Kohno,
J.-I. Kaddota,
M. Tohyama,
K. Teruya,
N. Kudeken,
A. Saito, and K. Hara.
1995.
T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN- and its protective effect against cryptococcal infection.
Microbiol. Immunol.
39:135-143[Medline].
|
| 21.
|
Kawakami, K.,
M. Tohyama,
X. Qifeng, and A. Saito.
1997.
Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12.
Infect. Immun.
65:1307-1312[Abstract].
|
| 22.
|
Kawakami, K.,
M. Tohyama,
O. Zie, and A. Saito.
1996.
IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans.
Clin. Exp. Immunol.
104:208-214[Medline].
|
| 23.
|
Kawakami, K.,
X. Wifeng,
M. Tohyama,
M. H. Qureshi, and A. Saito.
1996.
Contribution of tumour necrosis factor-alpha (TNF- ) in host defense mechanism against Cryptococcus neoformans.
Clin. Exp. Immunol.
106:468-474[Medline].
|
| 24.
|
Kozel, T. R., and E. C. Gotschlich.
1982.
The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
J. Immunol.
129:1675-1680[Abstract].
|
| 25.
|
Kwon-Chung, K. J., and J. E. Bennett.
1992.
Appendix B, p. 821-822.
In
Medical mycology. Lea & Febiger, Philadelphia, Pa.
|
| 26.
|
Kwon-Chung, K. J., and J. E. Bennett.
1992.
Cryptococcosis, p. 398-399.
In
Medical mycology. Lea & Febiger, Philadelphia, Pa.
|
| 27.
|
Lim, T. S.,
J. W. Murphy, and L. K. Cauley.
1980.
Host-etiological agent interactions in intranasally and intraperitoneally induced cryptococcosis in mice.
Infect. Immun.
29:633-641[Abstract/Free Full Text].
|
| 28.
|
Mitchell, T. G., and J. R. Perfect.
1995.
Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans.
Clin. Microbiol. Rev.
8:515-548[Abstract].
|
| 29.
|
Mody, C. H.,
C. L. Tyler,
R. G. Sitrin,
C. Jackson, and G. B. Toews.
1991.
Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity.
Am. J. Respir. Cell Mol. Biol.
5:19-26.
|
| 30.
|
Murphy, J. W.
1993.
Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response.
Infect. Immun.
61:4750-4759[Abstract/Free Full Text].
|
| 31.
|
Murphy, J. W.
1996.
Cell-mediated immunity, p. 67-97.
In
J. D. Miller, and D. H. Howard (ed.), The mycota, vol. VII. Animal and human relationships. Springer-Verlag, New York, N.Y.
|
| 32.
|
Nowak, T. P., and S. H. Barondes.
1975.
Agglutinin from Limulus polyphemus. Purification with formalinized horse erythrocytes as the affinity adsorbent.
Biochim. Biophys. Acta
393:115-123[Medline].
|
| 33.
|
Pape, K. A.,
R. Merica,
A. Mondino,
A. Khoruts, and M. K. Jenkins.
1998.
Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance.
J. Immunol.
160:4719-4729[Abstract/Free Full Text].
|
| 34.
|
Parry, S. L.,
M. Sebbag,
M. Feldmann, and F. M. Brennan.
1997.
Contact with T cells modulates monocyte IL-10 production. Role of T cell membrane TNF- .
J. Immunol.
158:3673-3681[Abstract].
|
| 35.
|
Puren, A. J.,
G. Fantuzzi,
Y. Gu,
M. S. Su, and C. A. Ginarello.
1998.
Interleukin-18 (IFN -inducing factor) induces IL-8 and IL-1 via TNF production from non-CD14+ human blood mononuclear cells.
J. Clin. Investig.
101:711-721[Medline].
|
| 36.
|
Vecchiarelli, A.,
C. Retini,
C. Monari,
C. Tascini,
F. Bistoni, and T. R. Kozel.
1996.
Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.
Infect. Immun.
64:2846-2849[Abstract].
|
| 37.
|
Yuan, R. R.,
A. Casadevall,
J. Oh, and M. D. Scharff.
1997.
T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.
Proc. Natl. Acad. Sci. USA
94:2483-2488[Abstract/Free Full Text].
|
Infection and Immunity, July 1999, p. 3601-3609, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Osterholzer, J. J., Surana, R., Milam, J. E., Montano, G. T., Chen, G.-H., Sonstein, J., Curtis, J. L., Huffnagle, G. B., Toews, G. B., Olszewski, M. A.
(2009). Cryptococcal Urease Promotes the Accumulation of Immature Dendritic Cells and a Non-Protective T2 Immune Response within the Lung. Am. J. Pathol.
174: 932-943
[Abstract]
[Full Text]
-
Regueiro, V., Moranta, D., Campos, M. A., Margareto, J., Garmendia, J., Bengoechea, J. A.
(2009). Klebsiella pneumoniae Increases the Levels of Toll-Like Receptors 2 and 4 in Human Airway Epithelial Cells. Infect. Immun.
77: 714-724
[Abstract]
[Full Text]
-
Jain, N., Li, L., Hsueh, Y.-P., Guerrero, A., Heitman, J., Goldman, D. L., Fries, B. C.
(2009). Loss of Allergen 1 Confers a Hypervirulent Phenotype That Resembles Mucoid Switch Variants of Cryptococcus neoformans. Infect. Immun.
77: 128-140
[Abstract]
[Full Text]
-
Guerrero, A., Fries, B. C.
(2008). Phenotypic Switching in Cryptococcus neoformans Contributes to Virulence by Changing the Immunological Host Response. Infect. Immun.
76: 4322-4331
[Abstract]
[Full Text]
-
Fries, B. C., Lee, S. C., Kennan, R., Zhao, W., Casadevall, A., Goldman, D. L.
(2005). Phenotypic Switching of Cryptococcus neoformans Can Produce Variants That Elicit Increased Intracranial Pressure in a Rat Model of Cryptococcal Meningoencephalitis. Infect. Immun.
73: 1779-1787
[Abstract]
[Full Text]
-
Hernandez, Y., Arora, S., Erb-Downward, J. R., McDonald, R. A., Toews, G. B., Huffnagle, G. B.
(2005). Distinct Roles for IL-4 and IL-10 in Regulating T2 Immunity during Allergic Bronchopulmonary Mycosis. J. Immunol.
174: 1027-1036
[Abstract]
[Full Text]
-
Blackstock, R., Murphy, J. W.
(2004). Age-Related Resistance of C57BL/6 Mice to Cryptococcus neoformans Is Dependent on Maturation of NKT Cells. Infect. Immun.
72: 5175-5180
[Abstract]
[Full Text]
-
Yauch, L. E., Mansour, M. K., Shoham, S., Rottman, J. B., Levitz, S. M.
(2004). Involvement of CD14, Toll-Like Receptors 2 and 4, and MyD88 in the Host Response to the Fungal Pathogen Cryptococcus neoformans In Vivo. Infect. Immun.
72: 5373-5382
[Abstract]
[Full Text]
-
Uezu, K., Kawakami, K., Miyagi, K., Kinjo, Y., Kinjo, T., Ishikawa, H., Saito, A.
(2004). Accumulation of {gamma}{delta} T Cells in the Lungs and Their Regulatory Roles in Th1 Response and Host Defense against Pulmonary Infection with Cryptococcus neoformans. J. Immunol.
172: 7629-7634
[Abstract]
[Full Text]
-
Olszewski, M. A., Noverr, M. C., Chen, G.-H., Toews, G. B., Cox, G. M., Perfect, J. R., Huffnagle, G. B.
(2004). Urease Expression by Cryptococcus neoformans Promotes Microvascular Sequestration, Thereby Enhancing Central Nervous System Invasion. Am. J. Pathol.
164: 1761-1771
[Abstract]
[Full Text]
-
Blackstock, R., Murphy, J. W.
(2004). Role of Interleukin-4 in Resistance to Cryptococcus neoformans Infection. Am. J. Respir. Cell Mol. Bio.
30: 109-117
[Abstract]
[Full Text]
-
Ulett, G. C., Ketheesan, N., Clair, T. W., McElnea, C. L., Barnes, J. L., Hirst, R. G.
(2002). Analogous Cytokine Responses to Burkholderia pseudomallei Strains Contrasting in Virulence Correlate with Partial Cross-Protection in Immunized Mice. Infect. Immun.
70: 3953-3958
[Abstract]
[Full Text]
-
Feldmesser, M., Mednick, A., Casadevall, A.
(2002). Antibody-Mediated Protection in Murine Cryptococcus neoformans Infection Is Associated with Pleotrophic Effects on Cytokine and Leukocyte Responses. Infect. Immun.
70: 1571-1580
[Abstract]
[Full Text]
-
Kawakami, K., Kinjo, Y., Uezu, K., Yara, S., Miyagi, K., Koguchi, Y., Nakayama, T., Taniguchi, M., Saito, A.
(2001). Monocyte Chemoattractant Protein-1-Dependent Increase of V{alpha}14 NKT Cells in Lungs and Their Roles in Th1 Response and Host Defense in Cryptococcal Infection. J. Immunol.
167: 6525-6532
[Abstract]
[Full Text]
-
Kawakami, K., Kinjo, Y., Yara, S., Uezu, K., Koguchi, Y., Tohyama, M., Azuma, M., Takeda, K., Akira, S., Saito, A.
(2001). Enhanced Gamma Interferon Production through Activation of Valpha 14+ Natural Killer T Cells by alpha -Galactosylceramide in Interleukin-18-Deficient Mice with Systemic Cryptococcosis. Infect. Immun.
69: 6643-6650
[Abstract]
[Full Text]
-
Retini, C., Kozel, T. R., Pietrella, D., Monari, C., Bistoni, F., Vecchiarelli, A.
(2001). Interdependency of Interleukin-10 and Interleukin-12 in Regulation of T-Cell Differentiation and Effector Function of Monocytes in Response to Stimulation with Cryptococcus neoformans. Infect. Immun.
69: 6064-6073
[Abstract]
[Full Text]
-
Olszewski, M. A., Huffnagle, G. B., Traynor, T. R., McDonald, R. A., Cook, D. N., Toews, G. B.
(2001). Regulatory Effects of Macrophage Inflammatory Protein 1{alpha}/CCL3 on the Development of Immunity to Cryptococcus neoformans Depend on Expression of Early Inflammatory Cytokines. Infect. Immun.
69: 6256-6263
[Abstract]
[Full Text]
-
Beenhouwer, D. O., Shapiro, S., Feldmesser, M., Casadevall, A., Scharff, M. D.
(2001). Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans. Infect. Immun.
69: 6445-6455
[Abstract]
[Full Text]
-
Kawakami, K., Kinjo, Y., Yara, S., Koguchi, Y., Uezu, K., Nakayama, T., Taniguchi, M., Saito, A.
(2001). Activation of V{alpha}14+ Natural Killer T Cells by {alpha}-Galactosylceramide Results in Development of Th1 Response and Local Host Resistance in Mice Infected with Cryptococcus neoformans. Infect. Immun.
69: 213-220
[Abstract]
[Full Text]
-
Blackstock, R., McElwee, N., Neller, E., Shaddix-White, J.
(2000). Regulation of Cytokine Expression in Mice Immunized with Cryptococcal Polysaccharide, a Glucuronoxylomannan (GXM), Associated with Peritoneal Antigen-Presenting Cells (APC): Requirements for GXM, APC Activation, and Interleukin-12. Infect. Immun.
68: 5146-5153
[Abstract]
[Full Text]
-
McGaha, T., Murphy, J. W.
(2000). CTLA-4 Down-Regulates the Protective Anticryptococcal Cell-Mediated Immune Response. Infect. Immun.
68: 4624-4630
[Abstract]
[Full Text]